RespireRx Pharmaceuticals Inc.
http://www.respirerx.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From RespireRx Pharmaceuticals Inc.
Pharma Facing Growing Risks From Geopolitics, Industry Leaders Warn
Industry leaders and experts at the Financial Times Pharma and Biotech Summit said the US relationship with China adds pressing risk to pharma.
As Biosecure Bill Mores Forward, Clock Ticking For Industry To Move Away From Chinese CDMOs
Pink Sheet infographic details the timeframes and potential extensions under the House version of the bill, which just cleared committee.
Deal Watch: AbbVie Pursues Novel Neuropsychiatric Drug Class With Gilgamesh
Plus transactions involving Sanofi/Fulcrum, Reneo/OnKure, Lilly/Mitsubishi Tanabe, Lantern/Oregon, Zydus/Eiger and more.
Senate Work On Biosecurity Issues Continues Even As House Is Current Focus Of Legislative Activity
US FDA Principal Deputy Commissioner Namandjé Bumpus recently attended a biotech-themed roundtable with the Senate Select Committee on Intelligence and national security officials as Congress’ pulls the FDA into its worries about Chinese influence of the pharma industry.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Cortex Pharmaceuticals, Inc.
- Pier Pharmaceuticals, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice